Literature DB >> 28762566

Urodynamics in patients with spinal cord injury: A clinical review and best practice paper by a working group of The International Continence Society Urodynamics Committee.

Brigitte Schurch1, Valerio Iacovelli2, Marcio A Averbeck3, Carda Stefano1, Waleed Altaweel4, Enrico Finazzi Agrò2.   

Abstract

AIMS: Urodynamics have been recommended and utilized in the evaluation of spinal cord injury (SCI) patients for many years, but there is no consensus on the optimal use and follow-up strategy for these patients. In the present manuscript, after reporting the available evidence, a working group of the Urodynamics Committee of the International Continence Society (ICS) provides the current knowledge and recommendations on patients' assessment, indications, role, technical aspects, and follow-up of urodynamic studies in SCI patients.
METHODS: The working group has analyzed the current available evidence-based literature leading to a Delphi consensus formation by the members of the working group. A set of questions derived from the search were answered online on several occasions by an international panel of specialists. A 1-day face-to-face meeting of the experts finalized the discussion. Recommendations and expert opinions were finally reviewed by all the members of the ICS Urodynamics Committee on SCI core panel.
RESULTS: Six experts participated in the four phases of the consensus process. Evidence was reviewed. There was substantial variability in the level and quality of detail reported across the literature yield. Several papers reported insufficient detail to allow synthesis of outcomes across studies. The findings of this preliminary review have been used to generate guidelines for best practice of urodynamics in SCI patients. The working group included recommendations for patients' pre-testing and urodynamic tests execution. Best practices were given as expert opinions where evidence was lacking.
CONCLUSION: Urodynamic is highly recommended for patients with SCI after a proper initial assessment. Regular urodynamic follow-up is recommended to avoid upper urinary tract damage. However, until now, there is limited evidence on how frequently urodynamic control should be performed.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  lower urinary tract dysfunction; spinal cord injury; urodynamics

Mesh:

Year:  2017        PMID: 28762566     DOI: 10.1002/nau.23369

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  4 in total

1.  Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury.

Authors:  A Balanca; A Even; C Malot; E Chartier-Kastler; P Denys; C Joussain
Journal:  World J Urol       Date:  2022-06-10       Impact factor: 3.661

2.  Prioritization of risk situations in neuro-urology: guidelines from Association Française d'Urologie (AFU), Association Francophone Internationale des Groupes d'Animation de la Paraplégie (A.F.I.G.A.P.), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d'UroDynamique et de Pelvi-Périnéologie (SIFUD-PP).

Authors:  Claire Hentzen; Xavier Biardeau; Nicolas Turmel; Rebecca Haddad; Elsa Bey; Gérard Amarenco; Pierre Denys; Véronique Phé; Marie Aimée Perrouin-Verbe; Benoit Peyronnet; Charles Joussain
Journal:  World J Urol       Date:  2021-08-17       Impact factor: 4.226

3.  Development of the Canadian Spinal Cord Injury Best Practice (Can-SCIP) Guideline: Methods and overview.

Authors:  Eleni M Patsakos; Mark T Bayley; Ailene Kua; Christiana Cheng; Janice Eng; Chester Ho; Vanessa K Noonan; Matthew Querée; B Catharine Craven
Journal:  J Spinal Cord Med       Date:  2021       Impact factor: 1.985

4.  Evaluation of the quality of published SCI clinical practice guidelines using the AGREE II instrument: Results from Can-SCIP expert panel.

Authors:  Eleni M Patsakos; B Catharine Craven; Ailene Kua; Christiana L Cheng; Janice Eng; Chester Ho; Vanessa K Noonan; Matthew Querée; Mark T Bayley
Journal:  J Spinal Cord Med       Date:  2021       Impact factor: 1.985

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.